Three-stage designs for monitoring clinical trials

DOI10.1080/03610929408831362zbMath0825.62197MaRDI QIDQ4843696

No author found.

Publication date: 17 August 1995

Published in: Communications in Statistics - Theory and Methods (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/03610929408831362

zbMATH Keywords

sample size; power; clinical trials; group sequential designs; three-stage designs

Mathematics Subject Classification ID

62-XX: Statistics

Uses Software

• AS 195

Cites Work

• Unnamed Item
• Unnamed Item
• Statistical approaches to interim monitoring of medical trials: A review and commentary
• Discrete Sequential Boundaries for Clinical Trials
• Algorithm AS 195: Multivariate Normal Probabilities with Error Bound
• Group sequential tests with censored survival data adjusting for covariates
• The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time
• Stochastically curtailed tests in long–term clinical trials
• An improved method for deriving optimal one-sided group sequential tests
• Optimum Double Sampling Tests of Given Strength I. The Normal Distribution
• Two-Stage Plans Compared with Fixed-Sample-Size and Wald SPRT Plans
• A New Procedure for Group Sequential Analysis in Clinical Trials
• Design and analysis of group sequential tests based on the type I error spending rate function
• Operating Characteristic Curves and Accept-Reject Rules for Two and Three Stage Screening Procedures
• Optimum Character of the Sequential Probability Ratio Test
• A Double Sample Test Procedure